CCEL vs FCX · P/E 490, rev $31.6M vs P/E 38, rev $13.26B
CryoCell International Inc (CCEL) versus Freeport-McMoran Copper & Gold Inc (FCX) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Latest reported CCEL revenue for 2025-11-30 was $31.6M. Net income was -$2.4M. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Not investment advice. Open the CCEL and FCX stock pages for the full models.
Not investment advice.